Can value’s decade of underperformance be reversed?
With three separate Covid-19 vaccines announced in November, value stocks have experienced somewhat of a recovery after a particularly trying year. But what are the long term prospects for value investing? Is a rotation away from growth, which has dominated the past decade, on the horizon? We spoke with Tom Becket, chief investment officer at Punter Southall Wealth, to get the perspective from a fund selector.